Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Ferrer-Marin F, Cuenca-Zamora EJ, Guijarro-Carrillo PJ, Teruel-Montoya R. Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms. Int J Mol Sci. 2021 Jan 24;22(3):1143. doi: 10.3390/ijms22031143. PubMed PMID: 33498945; PubMed Central PMCID: PMC7866001.
AÑO: 2021; IF: 6.208
33498945
Martin Garcia A, Mitroi C, Mazon Ramos P, Garcia Sanz R, Virizuela JA, Arenas M, Egocheaga Cabello I, Albert D, Anguita Sanchez M, Arrarte Esteban VI, Ayala de la Pena F, Bonanand Lozano C, Castro A, Castro Fernandez A, Cordoba R, Cosin-Sales J, Chaparro-Munoz M, Dalmau R, Drak Hernandez Y, Deiros Bronte L, Diez-Villanueva P, Escobar Cervantes C, Fernandez Redondo C, Garcia Rodriguez E, Lozano T, Marco Vera P, Martinez Monzonis A, Mesa D, Oristrell G, Palma Gamiz JL, Pedreira M, Reinoso-Barbero L, Rodriguez I, Serrano Antolin JM, Toral B, Torres Royo L, Velasco Del Castillo S, Vicente-Herrero T, Zatarain-Nicolas E, Tamargo J, Lopez Fernandez T. Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC. Rev Esp Cardiol (Engl Ed). 2021 May;74(5):438-448. doi: 10.1016/j.rec.2020.11.020. Epub 2021 Mar 10. English, Spanish. PubMed PMID: 33712348.
AÑO: 2021; IF: 6.975
33712348
Calderon C, Jimenez-Fonseca P, Hernandez R, Munoz MDM, Martinez de Castro E, Higuera O, Ghanem I, Castelo B, Rogado J, Carmona-Bayonas A. Prospective Study Comparing Clinicians' and Cancer Patients' Estimates of Risk of Relapse and Toxicity with Adjuvant Chemotherapy. Cancer Invest. 2021 Sep;39(8):589-596. doi: 10.1080/07357907.2021.1948561. Epub 2021 Jul 7. PubMed PMID: 34182858.
AÑO: 2021; IF: 2.368
34182858
Abrisqueta P, Loscertales J, Terol MJ, Ramirez Payer A, Ortiz M, Perez I, Cuellar-Garcia C, Fernandez de la Mata M, Rodriguez A, Lario A, Delgado J, Godoy A, Arguinano Perez JM, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Garcia Malo MD, Medina A, Garcia Martin P, Osorio S, Baltasar P, Fernandez-Zarzoso M, Marco F, Vidal Mancenido MJ, Smucler Simonovich A, Lopez Rubio M, Jarque I, Suarez A, Fernandez Alvarez R, Lancharro Anchel A, Rios E, Losada Castillo MDC, Perez Persona E, Garcia Munoz R, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva M. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). Clin Lymphoma Myeloma Leuk. 2021 Dec;21(12):e985-e999. doi: 10.1016/j.clml.2021.07.022. Epub 2021 Aug 3. PubMed PMID: 34511320.
AÑO: 2021; IF: 2.822
34511320
Boluda B, Martinez-Cuadron D, Algarra L, Cano I, Sayas MJ, Acuna-Cruz E, Blanco A, Marco-Ayala J, DeLapuerta R, Diaz-Gonzalez A, Tormo M, Rodriguez-Veiga R, Garcia R, Pinana JL, Lopez-Pavia M, Barragan E, Amigo ML, Sargas C, Lopez A, Solana-Altabella A, Gil C, Megias-Vericat JE, Sanz MA, Montesinos P. Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients. Leuk Lymphoma. 2021 Nov;62(11):2727-2736. doi: 10.1080/10428194.2021.1938031. Epub 2021 Jun 14. PubMed PMID: 34121593.
AÑO: 2021; IF: 2.996
34121593
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL